Turcios TSE, Infante AA, González RL

Language: Spanish
References: 16
Page:
PDF size: 255.96 Kb.

ABSTRACT

In the last few years, the frequency of diagnosis of the thyroid nodule has increased. A correct clinical method and some supplementary tests are the factors to be taken into account to define the nature of lesion and functionality. At present, new elements are added to the imaging studies, which help to predict somehow the risk of malignancy of these lesions, and it is intended to reach a more uniform and guiding cytological result. The behaviors should adapt to the type of thyroid disease and to the risks, but the combination of those specialties that have to do with the nodular thyroid disease is indispensable in order to uniform criteria favoring adequate and efficient diagnostic and therapeutic processes, and reducing the risks and costs of the adoption of inadequate and unnecessary behaviors.

REFERENCES

1. Cooper D, Doherty G, Haugen B, Kloos R, Lee S, Mandel S, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-716.

2. Gharib M, Gharib H. Guidelines for the diagnosis and management of thyroid nodules. Thyroid international. 2011;1:3-11.

3. Richards M. Familial syndromes associated with thyroid cancer in the era of personalized medicine. Thyroid. 2010;20:707-15.

4. Boelaerth K. The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer. 2009;16:1065-72.

5. Haymart M, Repplinger D, Leverson G, Elson D, Sippel R, Jaume J, et al. Higher serum TSH in thyroid nodule patients is associated with greater risk of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab. 2008;93:809-14.

6. Gharib H, Papini E, Paschke R, Duick D, Valcavi R, Hegedüs L, et al. American Association of Clinical Endocrinologists, Associaziones Medici Endocrinologi and European Thyroid Association Medical guidelines for Clinical Practice for the diagnosis and management of thyroid nodules. Endocr Practice. 2010;16:1-43.

7. Ferraz C, Eszlinger M, Paschke R. Current state and future perspective of molecular diagnosis of fine needle aspiration biopsy of thyroid nodule. JCEM. 2011;18:2016-26.

8. Paschke R, Hegedus L, Alexander E, Valcavi R, Papini E, Gharib H. Thyroid nodules guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol. 2011;7:354-61.

9. Sipos J. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid. 2009;19(12):1366-74.

10. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment and treatment. Endocrinol Metab Clin North Am. 2007;36(3):707-35.

11. Levine R. Current guidelines for the management of thyroid nodules. Endocr Pract. 2012;18(4):596-9.

12. Moon WJ, Baek JH, Jung SL. Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol. 2011;12:1-14.

13. Cibas E, Ali S. The Bethesta system for reporting thyroid cytopathology. Thyroid. 2009;19:1159-68.

14. Gharib H, Mazzaferri E. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med. 1998;128:386-94.

15. Papini E, Panunzi C, Pacella CM, Bizzarri G, Fabbrini R, Petrucci L. Percutaneous ultrasound guided ethanol injection: a new treatment of toxic autonomously functional thyroid nodules. J Clin Endocrinol Metab. 1993;76:411-6.

16. Vassiliadi D, Tagarakis S. Endocrine incidentalomas-challenges imposed by incidentally discovered lesions. Nat Rev Endocrinol. 2011;7:668-80.